These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7544975)

  • 1. Complement regulatory molecules: application to therapy and transplantation.
    Morgan BP
    Immunol Today; 1995 Jun; 16(6):257-9. PubMed ID: 7544975
    [No Abstract]   [Full Text] [Related]  

  • 2. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
    Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and analysis of transgenic pigs expressing the human complement regulatory protein CD59 and DAF.
    Byrne G; McCurry K; Martin M; Platt J; Logan J
    Transplant Proc; 1996 Apr; 28(2):759. PubMed ID: 8623385
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complement regulatory factors and immunologic recognition mechanism between species].
    Seya T; Matsunoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
    [No Abstract]   [Full Text] [Related]  

  • 6. Human complement regulatory proteins expressed in transgenic swine protect swine xenografts from humoral injury.
    McCurry KR; Diamond LE; Kooyman DL; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1996 Apr; 28(2):758. PubMed ID: 8623384
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Martin MJ; Logan JS; Platt JL
    Transplant Proc; 1995 Feb; 27(1):317-8. PubMed ID: 7533396
    [No Abstract]   [Full Text] [Related]  

  • 9. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S; van den Berg CW
    Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
    Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
    Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
    McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
    Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of complement regulatory factors using heterologous promoters in transgenic mice.
    Kagan D; Platt J; Logan J; Byrne GW
    Transplant Proc; 1994 Jun; 26(3):1242. PubMed ID: 7518118
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic engineering of the donor species to control hyperacute xenograft rejection.
    White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
    Adv Nephrol Necker Hosp; 1995; 24():331-40. PubMed ID: 7572417
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
    Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
    Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on transfer of primate membrane-associated complement inhibitors from recipient blood to porcine donor organs.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplant Proc; 1996 Apr; 28(2):601-2. PubMed ID: 8623295
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate functions of multiple complement regulating molecules, CD46, CD55, and CD59.
    Loveland BE; Szokolai K; Johnstone RW; McKenzie IF
    Transplant Proc; 1994 Jun; 26(3):1070-1. PubMed ID: 7518104
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement regulatory proteins and autoimmunity.
    Kawano M
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):367-72. PubMed ID: 11140463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.